Viagra Cannot Perform In Women: Pfizer Ends Female Sexual Arousal Disorder Studies
This article was originally published in The Pink Sheet Daily
Executive Summary
Clinical studies "do not support a regulatory filing" in female sexual dysfunction because efficacy data were "inconclusive," the company says.